Literature DB >> 1466892

Anxiety and depression in breast cancer patients at start of adjuvant radiotherapy. Relations to age and type of surgery.

R Maraste1, L Brandt, H Olsson, B Ryde-Brandt.   

Abstract

Using a self-report questionnaire, the Hospital Anxiety and Depression (HAD) scale, feelings of anxiety and depression were assessed in 133 breast cancer patients referred for adjuvant radiotherapy following surgical treatment. Eighteen patients (14%) had scores indicating morbid anxiety. Significant depression was recorded for only 2 patients (1.5%). Severe anxiety was recorded for 10 out of 54 mastectomized patients (19%) and for 8 out of 79 patients treated with breast conserving surgery (10%). The difference was not significant (p = 0.13). In a subgroup aged 50-59 years, morbid anxiety was significantly more common among mastectomized patients than among patients operated conservatively, 4 out of 9 (44%) vs. 1 out of 23 (4%) (p = 0.01). Such a pattern was not discernable in the patients < 50 years of age or those > or = 60 years old. The results suggest that, at start of adjuvant radiotherapy, emotional distress is characterized by anxiety rather than depression and the risk of morbid anxiety is especially large for mastectomized women in their fifties.

Entities:  

Mesh:

Year:  1992        PMID: 1466892     DOI: 10.3109/02841869209083846

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  11 in total

1.  Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor.

Authors:  Wing S Wong; Richard Fielding
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

2.  Factors that Affect Patients' Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients.

Authors:  Mahmut Gumus; Basak O Ustaalioglu; Meral Garip; Emre Kiziltan; Ahmet Bilici; Mesut Seker; Burcak Erkol; Taflan Salepci; Alpaslan Mayadagli; Nazim S Turhal
Journal:  Breast Care (Basel)       Date:  2010-05-27       Impact factor: 2.860

3.  Psychosocial sequelae of breast cancer and its treatment.

Authors:  A Moyer; P Salovey
Journal:  Ann Behav Med       Date:  1996-06

4.  Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer.

Authors:  Linda Witek Janusek; Dina Tell; Kevin Albuquerque; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2012-06-01       Impact factor: 7.217

5.  Prevalence of depression and its related factors among Chinese women with breast cancer.

Authors:  Xiaoli Chen; Ying Zheng; Wei Zheng; Kai Gu; Zhi Chen; Wei Lu; Xiao Ou Shu
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

6.  Exercise, tea consumption, and depression among breast cancer survivors.

Authors:  Xiaoli Chen; Wei Lu; Ying Zheng; Kai Gu; Zhi Chen; Wei Zheng; Xiao Ou Shu
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

7.  A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy.

Authors:  A J Munro; S Potter
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Clinical relevance of single item quality of life indicators in cancer clinical trials.

Authors:  J Bernhard; M Sullivan; C Hürny; A S Coates; C M Rudenstam
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

9.  Factors influencing psychological wellbeing of early breast cancer patients.

Authors:  Liliana DeMiglio; Victoria Murdoch; Jessica Ivison; Samarth Fageria; Ioannis A Voutsadakis
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-02

10.  Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

Authors:  J Bernhard; C Hürny; A S Coates; H F Peterson; M Castiglione-Gertsch; R D Gelber; E Galligioni; G Marini; B Thürlimann; J F Forbes; A Goldhirsch; H J Senn; C M Rudenstam
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.